Related to OncoMethylome to Carry Out MGMT Assay as Part of Roche’s Phase III Avastin Trial in Glioblastoma

• Invida to Market Roche’s Primary Care Portfolio in Korea
  
• AgenoLAB Becomes First German Lab to Purchase Roche’s RTCA Cardio Instrument
  
• Northwest Biotherapeutics Signs on Fraunhofer IZI for Brain Cancer Vaccine Development
  
• Roche’s HIV Prognostic Test Gets Expanded European Clearance
  
• Plexxikon and Roche Report Positive Data from Phase III BRAF Mutation Melanoma Study
  
• Merck KGaA to Use MDxHealth’s Assay in Second Clinical Glioblastoma Study
  
• Roche to Supply UCLA Centers with Technologies and Support for Biomarker Discovery
  
• FDA Clears Roche's Fully Automated Her2 Gene Status Diagnostic Assay
  
• Nycomed to Market Roche’s Osteoporosis Treatment in Asia Pacific
  
• Pivotal Study Results Lead Genentech to Project Vismodegib Filing in U.S. During 2011
  
• Roche Taps Evotec to Identify Biomarkers of Cancer Drug Activity and Patient Response
  
• EC Approves New Avastin Combination for Breast Cancer
  
• After Panel’s Vote, Fate of Avastin for MBC in U.S. Rests with FDA Commissioner
  
• Merck & Co. and Roche Go Global with Marketing for Victrelis in HCV
  
• EC Approves Roche’s RoActemra for Treating Active Systemic Juvenile Idiopathic Arthritis
  
• Genentech Takes Another Shot at Convincing FDA to Maintain Avastin’s Metastatic Breast Cancer Approval
  
• FDA Green-Lights Roche’s Melanoma Drug and Companion Diagnostic
  
• PerkinElmer to Take Over Distribution of NimbleGen CGX Cytogenetics Array Workflow from Roche
  
• Roche Pays Evotec $10M Up Front in Deal to Develop MAO-B Inhibitor for Alzheimer Disease
  
• Roche Establishes Links with Swedish Academic Innovation Initiative